A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this study is to evaluate the safety of the designed LMP1-CAR -T cells and determine whether the CAR-T cells are effective in the treatment of EBV associated malignant tumors.
Epistemonikos ID: 20498498ebfb876b630c11778981566349ad80eb
First added on: May 20, 2024